Dade Behring Launches Dimension Vista® 1500 Intelligent Lab System
DEERFIELD, Ill.–(BUSINESS WIRE)–Dade Behring Inc. (NASDAQ:DADE) today announced it has shipped its first Dimension Vista® 1500 Intelligent Lab Systems – the industry’s first ultra-integrated analyzer for high-volume clinical laboratories. Using four advanced detection technologies, the system provides laboratory personnel with the ability to efficiently perform a broad range of high-quality chemistry and immunochemistry tests on one analyzer.
The first shipments represent another key milestone in the company’s established plan for introducing the Dimension Vista® 1500 Intelligent Lab System to the clinical diagnostics market. The company previously received regulatory clearance for the analyzer and numerous tests.
“We are extremely proud to have shipped our first Dimension Vista Systems,” said Jim Reid-Anderson, Chairman, President and CEO, Dade Behring. “The Dimension Vista System is a new class of analyzer that will expand Dade Behring’s current leadership position in system integration, and help clinical laboratory customers improve their operational efficiency and productivity.”
Through the introduction of new LOCI™ Advanced Chemiluminescence Technology, the Dimension Vista® 1500 Intelligent Lab System provides clinical laboratories with the capability to run a broad menu of tests, which includes panels for cardiac disease, thyroid disorders, therapeutic drug monitoring, drugs-of-abuse testing, protein testing, and routine and specialty chemistry testing. In the future, the company intends to expand the test menu to offer among others, fertility, anemia, infectious disease diagnostic, and cancer marker monitoring tests.
About Dade Behring
With 2005 revenue of nearly $1.7 billion, Dade Behring is the world’s largest company solely dedicated to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at www.dadebehring.com.
